Paper7902829
Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice.
Pinski J and 3 others. Int J Cancer, 1993. Cited by 71 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice. Papers, record 7902829. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7902829
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Bombesin | Major topic |
| Carcinoma | Major topic |
| Peptide Fragments | Major topic |
| Prostatic Neoplasms | Major topic |
| Somatostatin | Major topic |
| Animals | |
| Cell Division | |
| ErbB Receptors | |
| Male | |
| Mice | |
| Mice, Nude | |
| Neoplasm Transplantation | |
| Organ Size | |
| Receptors, Bombesin | |
| Receptors, Somatostatin | |
| Transplantation, Heterologous | |
| Tumor Cells, Cultured |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA 40003 | NCI NIH HHS | United States | R01CA040003 | PubMed and NIH |
Source NIH RePORTER
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39,768,218 | GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma. | Cells | 2024 | https://conductscience.org/library/papers/39768218 | PubMed |
| 38,540,191 | The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review. | Biomedicines | 2024 | https://conductscience.org/library/papers/38540191 | PubMed |
| 38,203,605 | Somatostatin and Somatostatin Receptors in Tumour Biology. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38203605 | PubMed |
| 36,077,458 | PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077458 | PubMed |
| 34,810,259 | Exploring the signaling space of a GPCR using bivalent ligands with a rigid oligoproline backbone. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34810259 | PubMed |
| 20,182,713 | A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues. | Eur J Nucl Med Mol Imaging | 2010 | https://conductscience.org/library/papers/20182713 | PubMed |
| 9,465,096 | Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9465096 | PubMed |
| 9,380,734 | A single in vivo administration of bombesin antagonist RC-3095 reduces the levels and mRNA expression of epidermal growth factor receptors in MXT mouse mammary cancers. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9380734 | PubMed |
| 9,366,567 | Constitutive activation of the gastrin-releasing peptide receptor expressed by the nonmalignant human colon epithelial cell line NCM460. | J Clin Invest | 1997 | https://conductscience.org/library/papers/9366567 | PubMed |
| 7,740,652 | Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate. | Urol Res | 1995 | https://conductscience.org/library/papers/7740652 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EGF | 1,950 | PubTator's text mining | https://conductscience.org/library/genes/1950 | NCBI Gene |
| GAST | 2,520 | PubTator's text mining | https://conductscience.org/library/genes/2520 | NCBI Gene |
| GH1 | 2,688 | PubTator's text mining | https://conductscience.org/library/genes/2688 | NCBI Gene |
| GRP | 2,922 | PubTator's text mining | https://conductscience.org/library/genes/2922 | NCBI Gene |
| SST | 6,750 | PubTator's text mining | https://conductscience.org/library/genes/6750 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7902829
GET https://conductscience.org/api/papers/v1/7902829/authors